NCT04090099

Brief Summary

Inadequate pain relief after cardiac surgery increases morbidity and results in a high incidence of persistent poststernotomy pain syndrome. The use of special opioid-based analgesia causes adverse effects such as nausea, vomiting, sedation, urinary retention, respiratory depression and delayed tracheal extubation. Regional anesthesia techniques such as pectoralis nerve block and serratus anterior block provide analgesia in the sternum and pain relief in the lateral / posterior chest Wall. Erector spinae (ESP) block, a new and simple myofascial block, provides wide multi-dermatomal sensory block. In the T5 spinous process, bilateral ESP block provides analgesia from T2 to T9 sensory level, resulting in both somatic and visceral analgesia by blocking both the dorsal and ventral of the spinal nerves, including the sympathetic chain. This block may provide adequate analgesia for median sternotomy because the main nerve supply to the sternal region is from T2 to T6. Median sternotomy incision and mediastinal tube regions are the major source of pain in patients undergoing cardiac surgery. The anterior and posterior branches of the intercostal nerves give nerves to the sternum. Parasternal local anesthetic infiltration around the sternum is effective in providing early postoperative analgesia and reducing opioid requirements and therefore has positive effects on healing. This simple and fast technique can be used even for anticoagulated patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

September 17, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2022

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

2.1 years

First QC Date

September 13, 2019

Last Update Submit

February 3, 2024

Conditions

Keywords

Erector Spinae Block, Parasternal block, Cardiac surgery

Outcome Measures

Primary Outcomes (1)

  • Morphine consumption by PCA

    Morphine consumption used in case of pain

    Change from baseline 1 , 3, 6, 12 and 24 hours after extubation

Secondary Outcomes (3)

  • Change Pain Scores

    Time Frame: 1 hour,3 hours, 6 hours, 12 hours, 24 hours after the extubation

  • Change Blood Gas

    Change from Baseline at 60 minutes,2 hours, 4 hours, 6 hours, 12 hours, 24 hours after extübation ,

  • Blood Pressure

    Change from Baseline at 60 minutes,2 hours, 4 hours, 6 hours, 12 hours, 24 hours after extübation ,

Study Arms (3)

Group C

NO INTERVENTION

PCA (Patient controlled analgesia) and morphine consumption will be monitored in the postoperative period.

Group ES (Erector Spina Plane)

ACTIVE COMPARATOR

A high frequency (10-18 MHz) ultrasound linear probe covered with a sterile sheath will be placed 2 cm to the side of the T5 spinous process, first to the right or left. After demonstrating the T5 transverse process and the erector spinae muscle on top, the 22-gauge, 80 mm insulated Quincke-type needle will be inserted into the skin at an angle of about 30 degrees from the cranial to the caudal, using an in-plane technique. When the transverse process is touched, the needle is withdrawn and after a negative aspiration test with 0.5 mL of normal saline and after a hypo-echogenic display and hydrodissection, a local anesthetic solution will be applied to the fascia under the erector spinae muscle. A dose of 0.25% bupivacaine will be injected which is shown to spread both above and below the T5 level. The same process will be implemented on the other side.

Other: Erector spina plane block

Group PS (Para Sternal Block)

ACTIVE COMPARATOR

Before the wire is inserted into the sternum, the sternotomy and mediastinal tube regions will be infiltrated with a mixture of bupivacaine and saline.

Other: Erector spina plane block

Interventions

While the patient is in the sitting position, an area containing 2 cm lateral of the T5 spinous process will be cleaned with povidone iodine. A high frequency ultrasound linear probe covered with a sterile sheath will be placed 2 cm to the side of the T5 spinous process, first to the right or left. After demonstrating the T5 transverse process and the erector spinae muscle on top, the 22-gauge, 80 mm insulated Quincke-type needle will be inserted into the skin at an angle of about 30 degrees from the cranial to the caudal, using an in-plane technique. When the transverse process is touched, the needle is withdrawn and after a negative aspiration test with 0.5 mL of normal saline and after a hypo-echogenic display and hydrodissection, a local anesthetic solution will be applied to the fascia under the erector spinae muscle.

Group ES (Erector Spina Plane)Group PS (Para Sternal Block)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and / or female patients
  • Aged 18-65 years
  • Patients who will have coronary artery surgery under cardiopulmonary baypass (changing one, two and three vessels) with normal left ventricular function,
  • Valve diseases with normal left ventricular function,
  • ASD (Atrial Septal Defect) cases for atrial septal defect closure
  • Patients with valve + CABG without left ventricular dysfunction will be included in the study.
  • Ejection- Fraction\> 50-55

You may not qualify if:

  • Emergency and repeat heart surgery cases
  • Advanced left coronary artery disease and left ventricular dysfunction
  • Receiving preoperative inotropic support therapy,
  • With mitral stenosis with atrial tombus,
  • With low cardiac out put syndrome,
  • Need intra-aortic balloon pump during surgery,
  • Bleeding and coagulation disorder,
  • Liver and kidney dysfunction,
  • Patients with uncontrolled diabetes mellitus and coronary artery pulmonary disease,
  • Opioid, analgesic and bupivacaine allergy,
  • Patients with atrial fbrilation using anticoagulants
  • Patients with cognitive dysfunction
  • Patients who do not want to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kahramanmaras Sutcu Imam Univercity Faculty of edicine

Kahramanmaraş, Onikişubat, 251/A 46040, Turkey (Türkiye)

Location

Kahramanmaras Sutcu Imam University Faculty of Medicine

Kahramanmaraş, Onikişubat, 251/A 46040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • yavuz orak, md

    Kahramanmaraş Sutcu Imam University Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 13, 2019

First Posted

September 16, 2019

Study Start

September 17, 2019

Primary Completion

October 14, 2021

Study Completion

May 15, 2022

Last Updated

February 6, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations